Display Settings:

Format

Send to:

Choose Destination
    Scand J Rheumatol. 1994;23(4):211-4.

    Double blind radiological assessment of continuous oral pamidronic acid in patients with rheumatoid arthritis.

    Source

    Department of Rheumatology, French Hospital, Buenos Aires, Argentina.

    Abstract

    Continuous oral pamidronate (APD), 1000 mg/day, was administered to 14 patients with rheumatoid arthritis. A control group of 13 patients with similar conditions received placebo under a double blind randomized study design. Periarticular erosion scores were significantly higher in the control group after 12 months treatment. This was attributed to a deterioration in this group rather than to an improvement in the APD treated one. By contrast, intraarticular narrowing score was not influenced by APD. Tolerance to oral APD was acceptable in all patients.

    PMID:
    8091148
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk